By Karen Roman
Biopharmaceutical company ReAlta Life Sciences said it designated immunologist Laurie Glimcher, M.D., to its Board of Directors.
Dr. Glimcher is renowned for her 35 years of work in cancer research, and she is the Richard and Susan Smith Distinguished Professor of Medicine at Harvard Medical School, the company stated.
“She is a trailblazer in immunology and cancer research, and her expertise and understanding of drug development innovation at the highest levels will be invaluable as we continue advancing our clinical pipeline across diseases in immunology and inflammation,” said David Marek, ReAlta CEO.
Contact:
